Your browser doesn't support javascript.
loading
Cost-Effectiveness Analysis of Bariatric Surgery for Morbid Obesity.
Alsumali, Adnan; Eguale, Tewodros; Bairdain, Sigrid; Samnaliev, Mihail.
Afiliación
  • Alsumali A; Department of Pharmaceutical Business and Administrative Sciences, MCPHS University, Boston, MA, 02115, USA. adnanalsumali@gmail.com.
  • Eguale T; Department of Pharmaceutical Business and Administrative Sciences, MCPHS University, Boston, MA, 02115, USA.
  • Bairdain S; Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Boston, MA, USA.
  • Samnaliev M; Department of Surgery, George Washington University, Washington, DC, USA.
Obes Surg ; 28(8): 2203-2214, 2018 08.
Article en En | MEDLINE | ID: mdl-29335933
BACKGROUND: In the USA, three types of bariatric surgeries are widely performed, including laparoscopic sleeve gastrectomy (LSG), laparoscopic Roux-en-Y gastric bypass (LRYGB), and laparoscopic adjustable gastric banding (LAGB). However, few economic evaluations of bariatric surgery are published. There is also scarcity of studies focusing on the LSG alone. Therefore, this study is evaluating the cost-effectiveness of bariatric surgery using LRYGB, LAGB, and LSG as treatment for morbid obesity. METHODS: A microsimulation model was developed over a lifetime horizon to simulate weight change, health consequences, and costs of bariatric surgery for morbid obesity. US health care prospective was used. A model was propagated based on a report from the first report of the American College of Surgeons. Incremental cost-effectiveness ratios (ICERs) in terms of cost per quality-adjusted life-year (QALY) gained were used in the model. Model parameters were estimated from publicly available databases and published literature. RESULTS: LRYGB was cost-effective with higher QALYs (17.07) and cost ($138,632) than LSG (16.56 QALYs; $138,925), LAGB (16.10 QALYs; $135,923), and no surgery (15.17 QALYs; $128,284). Sensitivity analysis showed initial cost of surgery and weight regain assumption were very sensitive to the variation in overall model parameters. Across patient groups, LRYGB remained the optimal bariatric technique, except that with morbid obesity 1 (BMI 35-39.9 kg/m2) patients, LSG was the optimal choice. CONCLUSION: LRYGB is the optimal bariatric technique, being the most cost-effective compared to LSG, LAGB, and no surgery options for most subgroups. However, LSG was the most cost-effective choice when initial BMI ranged between 35 and 39.9 kg/m2.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Obesidad Mórbida / Cirugía Bariátrica Tipo de estudio: Health_economic_evaluation / Observational_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Aged80 País/Región como asunto: America do norte Idioma: En Revista: Obes Surg Asunto de la revista: METABOLISMO Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Obesidad Mórbida / Cirugía Bariátrica Tipo de estudio: Health_economic_evaluation / Observational_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Aged80 País/Región como asunto: America do norte Idioma: En Revista: Obes Surg Asunto de la revista: METABOLISMO Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos